The course will also review cardiovascular risk in patients with thyroid disorders, including heart failure with Graves disease, myxedema and thyroid hormone replacement.A special research presentation on lipid droplet biology will highlight important ongoing research in lipid metabolism. The course will provide updates on the role of inflammation, hypertriglyceridemia, and lipoprotein(a) in cardiovascular disease risk.

A special research presentation on lipid droplet biology will highlight important ongoing research in lipid metabolism. The course will provide updates on the role of inflammation, hypertriglyceridemia, and lipoprotein(a) in cardiovascular disease risk. There will be an hour-long case conference with challenging cases in cardiovascular disease risk reduction. The course includes morning and afternoon panel discussion segments including an audience question-and-answer time

This symposium is designed to provide a dedicated forum to discuss the diagnosis and management of patients with coronary artery anomalies (CAA). Topics will include anomalous aortic origin of a coronary artery (AAOCA) and myocardial bridges.